Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients

Medical Mycology

Volumn 45, Issue 6, 2007, Pages 513-518

  Meletiadis, Joseph ^a   Walsh, Thomas J ^a   Choi, Eun Hwa ^a   Pappas, Peter G ^b   Ennis, David ^b   Douglas, Jeffrey ^b   Pankey, George A ^c   Larsen, Robert A ^d   Hamill, Richard J ^e   Chanock, Stephen ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Candidate gene association studies; Cryptococcosis; Cryptococcus neoformans; Genetic polymorphisms; Haplotype analysis

Indexed keywords

FC RECEPTOR; FC RECEPTOR 3B; FC RECEPTOR IIA; FC RECEPTOR IIIA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; RISK FACTOR;

ANTIGENS, CD; CASE-CONTROL STUDIES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HIV SERONEGATIVITY; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RISK FACTORS;

FILOBASIDIELLA NEOFORMANS;

EID: 34548223285     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701390140     Document Type: Article

References (22)

1. Hajjeh, RA, Conn, LA and Stephens, DS (1999) Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis, 179, pp. 449-454.
2. Pappas, PG, Perfect, JR and Cloud, GA (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis, 33, pp. 690-699.
3. Perfect, JR and Casadevall, A. (2002) Cryptococcosis. Infect Dis Clin North Am, 16, pp. 837-874.
4. Cohen-Solal, JF, Cassard, L., Fridman, WH and Sautes-Fridman, C. (2004) Fc gamma receptors. Immunol Lett, 92, pp. 199-205.
5. Stefanescu, RN, Olferiev, M., Liu, Y. and Pricop, L. (2004) Inhibitory Fc gamma receptors: From gene to disease. J Clin Immunol, 24, pp. 315-326.
6. van Sorge, NM, van der Pol, WL and van de Winkel, JG. (2003) FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens, 61, pp. 189-202.
7. Lehrnbecher, T., Foster, CB and Zhu, S. (1999) Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood, 94, pp. 4220-4232.
8. Taylor, JG, Tang, D. and Foster, CB (2002) Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease. Am J Hematol, 69, pp. 109-114.
9. Edberg, JC and Redecha, PB (1997) A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest, 100, pp. 1059-1070.
10. Jiang, XM, Arepally, G., Poncz, M. and McKenzie, SE. (1996) Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods, 199, pp. 55-59.
11. Hessner, MJ, Curtis, BR, Endean, DJ and Aster, RH. (1996) Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion, 36, pp. 895-899.
12. Stephens, M., Smith, NJ and Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet, 68, pp. 978-989.
13. Van Dam, MG, Seaton, RA and Hamilton, AJ. (1998) Analysis of HLA association in susceptibility to infection with Cryptococcus neoformans var. gattii in a Papua New Guinean population. Med Mycol, 36, pp. 185-188.
14. Vecchiarelli, A. (2005) The cellular responses induced by the capsular polysaccharide of Cryptococcus neoformans differ depending on the presence or absence of specific protective antibodies. Curr Mol Med, 5, pp. 413-420.
15. Yuan, R., Clynes, R., Ravetch, JV and Scharff, MD. (1998) Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med, 187, pp. 641-648.
16. Zhong, Z. and Pirofski, LA. (1996) Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies. Infect Immun, 64, pp. 3446-3450.
17. Syme, RM, Spurrell, JC, Amankwah, EK, Green, FH and Mody, CH. (2002) Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun, 70, pp. 5972-5981.
18. Monari, C., Kozel, TR and Paganelli, F. (2006) Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor. J Immunol, 177, pp. 6842-6851.
19. Warmerdam, PA, Parren, PW and Vlug, A. (1992) Polymorphism of the human Fc gamma receptor II (CD32): Molecular basis and functional aspects. Immunobiology, 185, pp. 175-182.
20. Koene, HR, Kleijer, M. and Algra, J. (1997) Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood, 90, pp. 1109-1114.
21. Salmon, JE, Millard, SS, Brogle, NL and Kimberly, RP. (1995) Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest, 95, pp. 2877-2885.
22. Kyogoku, C., Tsuchiya, N., Matsuta, K. and Tokunaga, K. (2002) Studies on the association of Fc gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: Evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes Immun, 3, pp. 488-493.